Arrhythmia(atrial premature beats, ventricular premature beats)
Conditions
Interventions
first:placebo
second:wenxin keli
Sponsors
Fuwai Cardiovascular Institute & Heart Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. diagnostic criteria in line with arrhythmias (atrial premature beats, ventricular premature beats); 2. Premature beats> 360 beats / hour or> 8640/24 hours; 3. Are taking anti-arrhythmic drugs are disabled for more than a half-life of 5; 4. Aged 18 to 75-year-old, male or female; 5. Voluntary subjects and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Serious condition be combined with other drug treatment; 2. Arrhythmia caused by drugs, electrolyte or acid-base balance disorders and other factors; 3. The slow arrhythmia(Including sick sinus syndrome and II degree atrioventricular block); 4. Removal of incentives (such as fatigue, nervousness, mood swings, alcoholism, etc.) after premature to reduce symptoms remission; 5. Have a pacemaker or heart PCI surgery; 6. Patients with severe hypotension; 7. Patients with severe heart (congestive heart failure, cardiogenic shock), cerebrovascular diseases, liver, kidney and hematopoietic system such as severe primary disease (ALT and AST, BUN, higher than 2 times the upper limit of normal, or Cr and highthe upper limit of normal); 8. The known composition of the test drug allergy and allergic; 9. Pregnancy and lactating women, recently prepared, pregnancy; 10. Long-term alcoholism, drug dependence, mental illness; 11. Participated in other clinical trials in the three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Holter;12 - lead EC; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver and kidney function, Lipids, Blood sugar; | — |
Countries
China
Contacts
Public ContactHua Wei
Outcome results
None listed